REFERENCES
- Gudin, J. References risk evaluation and mitigation strategies (REMS) for extended-release and long-acting opioid analgesics: considerations palliative care practice. J Pain Palliat Care Pharmacother. 2012;26:136–143.
- Dusetzina SB, Higashi AS, Dorsey ER, Conti R, Huskamp HA, Zhu S, Garfield CF, Alexander GC. Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review. Med Care. 2012 Jun;50(6):466–478.
- American Academy of Pain Medicine. Statement on “FDA REMS on opioids.” Available at: http://www.painmed.org/1ColNoCallout.aspx?pageid = 2499. Accessed March 20, 2012.
- Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2011. NSDUH Series H-41, HHS Publication No. (SMA) 11-4658.
- IMS Institute for Healthcare Informatics. The use of medicines in the United States: review of 2010. Available at: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/IMS%20Institute/Static%20File/IHII_UseOfMed_report.pdf. Accessed March 20, 2012.